List of insiders holdings for Rubius Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Flagship Ventures Fund IV General Partner LLC Flagship VentureLabs IV LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR KANIA EDWIN M JR Director 10% Owner | 2022-02-14 15:00:29 | 38,581,526 0 | 38,581,526 | Form 13G |
| Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner | 2022-02-14 15:00:29 | 38,581,526 0 | 38,581,526 | Form 13G |
| NISSEN TORBEN STRAIGHT President | 2019-07-26 19:06:01 | 2,310,304 0 | 2,310,304 | Form 4 |
| OH ANDREW M. Chief Financial Officer | 2020-05-19 20:02:19 | 760,500 0 | 760,500 | Form 4 |
| CARPENTER CHRISTOPHER L. Chief Medical Officer | 2019-12-18 19:50:58 | 558,000 0 | 558,000 | Form 4 |
| Epstein David R Director | 2022-05-13 16:20:22 | 499,762 0 | 499,762 | Form 4 |
| Keson-Brookes Maiken CLO & Corp. Secretary | 2022-02-01 21:19:00 | 207,818 0 | 207,818 | Form 4 |
| Carmona Jose Chief Financial Officer | 2022-02-01 21:20:24 | 178,250 0 | 178,250 | Form 4 |
| Coughlin Christina M. Chief Medical Officer | 2021-02-02 20:27:22 | 174,800 0 | 174,800 | Form 4 |
| LANGER ROBERT Director | 2019-10-17 06:01:02 | 120,000 0 | 120,000 | Form 4 |
| CAGNONI PABLO J Director | 2023-02-01 21:41:05 | 66,082 0 | 66,082 | Form 4 |
| Turka Laurence A. Chief Scientific Officer | 2023-01-31 21:50:16 | 59,140 0 | 59,140 | Form 4 |
| Schaffert Susanne Director | 2022-08-01 17:38:45 | 50,000 0 | 50,000 | Form 4 |
| Sohn Catherine A. Director | 2022-05-13 16:26:35 | 25,000 0 | 25,000 | Form 4 |
| Symonds Jonathan Director | 2022-05-13 16:22:19 | 25,000 0 | 25,000 | Form 4 |
| AFEYAN NOUBAR Director 10% Owner | 2022-05-13 16:24:58 | 25,000 0 | 25,000 | Form 4 |
| Holles Natalie C. Director | 2022-05-13 16:33:15 | 25,000 0 | 25,000 | Form 4 |
| Prener Anne Director | 2022-05-13 16:35:26 | 25,000 0 | 25,000 | Form 4 |
| Cuss Francis M Director | 2022-05-13 16:31:17 | 25,000 0 | 25,000 | Form 4 |
| Rosenblatt Michael Director | 2022-05-13 16:28:53 | 25,000 0 | 25,000 | Form 4 |
| Pomerantz Roger Director | 2018-07-23 16:33:49 | 100 0 | 100 | Form 4 |
| Appelhans Dannielle CEO and President | 2023-02-27 18:08:34 | 0 0 | 0 | Form 4 |